As oncology research continues to advance, understanding the clinical significance of emerging evidence is essential for informing treatment strategies and guiding future research. The European Society for Medical Oncology (ESMO) Congress 2026 brought together healthcare professionals, researchers and industry experts to examine the latest advances in cancer research, treatment and clinical practice.
This webinar will explore key clinical trial results and advances in cancer therapies presented at ESMO 2026, with a focus on their implications for cancer treatment and oncology drug development. By examining these findings alongside existing treatment approaches, the discussion will highlight opportunities to improve patient care and advance therapeutic development.
The featured speakers will place these findings in the context of current evidence, examining their relevance to treatment decisions, remaining uncertainties and priorities for further research. Participants will gain a concise overview of the key messages presented at the congress and their significance for cancer care and oncology development programs.
Register for this webinar to learn how key findings from ESMO 2026 may inform clinical decision-making, cancer treatment strategies and future oncology research.
Who Should Attend
This webinar will appeal to professionals across the following roles and functions seeking a concise, clinically relevant update on ESMO 2026:
Medical/Clinical Oncologists
Oncology Fellows and Trainees
Clinical Researchers
Medical Affairs professionals
Medical Directors
Translational Medicine Scientists
Pharmaceutical and biotechnology R&D professionals
Register free on Xtalks: https://xtalks.com/webinars/esmo-2026-key-findings-for-cancer-care-and-drug-development/
